메뉴 건너뛰기




Volumn 5, Issue , 2015, Pages

Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus

Author keywords

[No Author keywords available]

Indexed keywords

COMPLICATION; DEMOGRAPHY; FECES; FEMALE; HOSPITALIZATION; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA; LIVER CIRRHOSIS; MALE; MICROBIOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRINCIPAL COMPONENT ANALYSIS; STATISTICAL MODEL; TREATMENT OUTCOME;

EID: 84951859197     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18559     Document Type: Article
Times cited : (68)

References (41)
  • 1
    • 84870532473 scopus 로고    scopus 로고
    • Second infections independently increase mortality in hospitalized patients with cirrhosis: The North American consortium for the study of end-stage liver disease (NACSELD) experience
    • Bajaj, J. S. et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology 56, 2328-2335 (2012).
    • (2012) Hepatology , vol.56 , pp. 2328-2335
    • Bajaj, J.S.1
  • 2
    • 84906793985 scopus 로고    scopus 로고
    • Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C
    • Elkrief, L. et al. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C. Hepatology 60, 823-831, doi: 10.1002/hep.27228 (2014).
    • (2014) Hepatology , vol.60 , pp. 823-831
    • Elkrief, L.1
  • 3
    • 77958604153 scopus 로고    scopus 로고
    • High prevalence of diabetes mellitus in patients with liver cirrhosis
    • Wlazlo, N. et al. High prevalence of diabetes mellitus in patients with liver cirrhosis. Diabet Med 27, 1308-1311 (2010).
    • (2010) Diabet Med , vol.27 , pp. 1308-1311
    • Wlazlo, N.1
  • 4
    • 0033983645 scopus 로고    scopus 로고
    • Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease
    • Zein, N. N., Abdulkarim, A. S., Wiesner, R. H., Egan, K. S. & Persing, D. H. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. Journal of hepatology 32, 209-217 (2000).
    • (2000) Journal of Hepatology , vol.32 , pp. 209-217
    • Zein, N.N.1    Abdulkarim, A.S.2    Wiesner, R.H.3    Egan, K.S.4    Persing, D.H.5
  • 5
    • 84856722705 scopus 로고    scopus 로고
    • Hospital readmissions among patients with decompensated cirrhosis
    • Volk, M. L., Tocco, R. S., Bazick, J., Rakoski, M. O. & Lok, A. S. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol 107, 247-252, doi: 10.1038/ajg.2011.314 (2012).
    • (2012) Am J Gastroenterol , vol.107 , pp. 247-252
    • Volk, M.L.1    Tocco, R.S.2    Bazick, J.3    Rakoski, M.O.4    Lok, A.S.5
  • 6
    • 84942022353 scopus 로고    scopus 로고
    • Decompensated cirrhosis and microbiome interpretation
    • Bajaj, J. S., Betrapally, N. S. & Gillevet, P. M. Decompensated cirrhosis and microbiome interpretation. Nature, doi: 10.1038/nature14851 (2015).
    • (2015) Nature
    • Bajaj, J.S.1    Betrapally, N.S.2    Gillevet, P.M.3
  • 7
    • 84928580431 scopus 로고    scopus 로고
    • Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy?
    • Shawcross, D. L. Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy? Expert review of gastroenterology & hepatology 9, 539-542, doi: 10.1586/17474124.2015.1035257 (2015).
    • (2015) Expert Review of Gastroenterology & Hepatology , vol.9 , pp. 539-542
    • Shawcross, D.L.1
  • 8
    • 84907225684 scopus 로고    scopus 로고
    • Alterations of the human gut microbiome in liver cirrhosis
    • Qin, N. et al. Alterations of the human gut microbiome in liver cirrhosis. Nature, doi: 10.1038/nature13568 (2014).
    • (2014) Nature
    • Qin, N.1
  • 9
    • 84867074831 scopus 로고    scopus 로고
    • A metagenome-wide association study of gut microbiota in type 2 diabetes
    • Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60, doi: 10.1038/nature11450 (2012).
    • (2012) Nature , vol.490 , pp. 55-60
    • Qin, J.1
  • 10
    • 84883181684 scopus 로고    scopus 로고
    • Human gut microbiota changes reveal the progression of glucose intolerance
    • Zhang, X. et al. Human gut microbiota changes reveal the progression of glucose intolerance. PloS one 8, e71108, doi: 10.1371/journal. pone.0071108 (2013).
    • (2013) PloS One , vol.8
    • Zhang, X.1
  • 11
    • 84884353768 scopus 로고    scopus 로고
    • An automated model using electronic medical record data identifies patients with cirrhosis at high risk for readmission
    • Singal, A. G. et al. An automated model using electronic medical record data identifies patients with cirrhosis at high risk for readmission. Clin Gastroenterol Hepatol 11, 1335-1341 e1331, doi: 10.1016/j.cgh.2013.03.022 (2013).
    • (2013) Clin Gastroenterol Hepatol , vol.11 , pp. 1335-1341
    • Singal, A.G.1
  • 12
    • 84922392216 scopus 로고    scopus 로고
    • Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function
    • Bajaj, J. S. et al. Systems Biology Analysis of Omeprazole Therapy in Cirrhosis Demonstrates Significant Shifts in Gut Microbiota Composition and Function. Am J Physiol Gastrointest Liver Physiol, doi: 10.1152/ajpgi.00268.2014 (2014).
    • (2014) Am J Physiol Gastrointest Liver Physiol
    • Bajaj, J.S.1
  • 13
    • 79951687159 scopus 로고    scopus 로고
    • Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease
    • Berman, K. et al. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. Clin Gastroenterol Hepatol 9, 254-259, doi: 10.1016/j.cgh.2010.10.035 (2011).
    • (2011) Clin Gastroenterol Hepatol , vol.9 , pp. 254-259
    • Berman, K.1
  • 14
    • 84898830272 scopus 로고    scopus 로고
    • Altered profile of human gut microbiome is associated with cirrhosis and its complications
    • Bajaj, J. S. et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. Journal of hepatology 60, 940-947, doi: 10.1016/j.jhep.2013.12.019 (2014).
    • (2014) Journal of Hepatology , vol.60 , pp. 940-947
    • Bajaj, J.S.1
  • 15
    • 79960714764 scopus 로고    scopus 로고
    • Characterization of fecal microbial communities in patients with liver cirrhosis
    • Chen, Y. et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54, 562-572 (2011).
    • (2011) Hepatology , vol.54 , pp. 562-572
    • Chen, Y.1
  • 16
    • 84937890366 scopus 로고    scopus 로고
    • Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality
    • Chen, Y. et al. Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality. J Gastroenterol Hepatol, doi: 10.1111/jgh.12932 (2015).
    • (2015) J Gastroenterol Hepatol
    • Chen, Y.1
  • 17
    • 84942553486 scopus 로고    scopus 로고
    • Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy
    • Bajaj, J. S. et al. Salivary Microbiota Reflects Changes in Gut Microbiota in Cirrhosis with Hepatic Encephalopathy. Hepatology, doi: 10.1002/hep.27819 (2015).
    • (2015) Hepatology
    • Bajaj, J.S.1
  • 18
    • 79959496268 scopus 로고    scopus 로고
    • Diversity of the autochthonous colonic microbiota
    • Nava, G. M. & Stappenbeck, T. S. Diversity of the autochthonous colonic microbiota. Gut Microbes 2 (2011). doi: 10.4161/gmic.2.2.15416
    • (2011) Gut Microbes , vol.2
    • Nava, G.M.1    Stappenbeck, T.S.2
  • 19
    • 84876294967 scopus 로고    scopus 로고
    • Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
    • Kakiyama, G. et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. Journal of hepatology 58, 949-955 (2013).
    • (2013) Journal of Hepatology , vol.58 , pp. 949-955
    • Kakiyama, G.1
  • 20
    • 84928171161 scopus 로고    scopus 로고
    • Cephalosporinases associated with outer membrane vesicles released by Bacteroides spp. Protect gut pathogens and commensals against beta-lactam antibiotics
    • Stentz, R. et al. Cephalosporinases associated with outer membrane vesicles released by Bacteroides spp. protect gut pathogens and commensals against beta-lactam antibiotics. J Antimicrob Chemother 70, 701-709, doi: 10.1093/jac/dku466 (2015).
    • (2015) J Antimicrob Chemother , vol.70 , pp. 701-709
    • Stentz, R.1
  • 21
    • 78650370258 scopus 로고    scopus 로고
    • Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease
    • Manges, A. R. et al. Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease. J Infect Dis 202, 1877-1884, doi: 10.1086/657319 (2010).
    • (2010) J Infect Dis , vol.202 , pp. 1877-1884
    • Manges, A.R.1
  • 22
    • 0344002716 scopus 로고    scopus 로고
    • Bacterial infection in cirrhotic patients and its relationship with alcohol
    • Rosa, H., Silverio, A. O., Perini, R. F. & Arruda, C. B. Bacterial infection in cirrhotic patients and its relationship with alcohol. Am J Gastroenterol 95, 1290-1293 (2000).
    • (2000) Am J Gastroenterol , vol.95 , pp. 1290-1293
    • Rosa, H.1    Silverio, A.O.2    Perini, R.F.3    Arruda, C.B.4
  • 23
    • 84862276328 scopus 로고    scopus 로고
    • Structure, function and diversity of the healthy human microbiome
    • Human Microbiome Project, C. Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214, doi: 10.1038/nature11234 (2012).
    • (2012) Nature , vol.486 , pp. 207-214
    • Human Microbiome Project, C,1
  • 24
    • 84856957894 scopus 로고    scopus 로고
    • Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
    • Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179-185, doi: 10.1038/nature10809 (2012).
    • (2012) Nature , vol.482 , pp. 179-185
    • Henao-Mejia, J.1
  • 25
    • 69249166158 scopus 로고    scopus 로고
    • Secondary prophylaxis of hepatic encephalopathy: An open-label randomized controlled trial of lactulose versus placebo
    • 891 e881
    • Sharma, B. C., Sharma, P., Agrawal, A. & Sarin, S. K. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology 137, 885-891, 891 e881, doi: 10.1053/j.gastro.2009.05.056 (2009).
    • (2009) Gastroenterology , vol.137 , pp. 885-891
    • Sharma, B.C.1    Sharma, P.2    Agrawal, A.3    Sarin, S.K.4
  • 26
    • 84875670330 scopus 로고    scopus 로고
    • Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy
    • Bajaj, J. S. et al. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PloS one 8, e60042, doi: 10.1371/journal.pone.0060042 (2013).
    • (2013) PloS One , vol.8
    • Bajaj, J.S.1
  • 27
    • 77950246404 scopus 로고    scopus 로고
    • Rifaximin treatment in hepatic encephalopathy
    • Bass, N. M. et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362, 1071-1081, doi: 10.1056/NEJMoa0907893 (2010).
    • (2010) N Engl J Med , vol.362 , pp. 1071-1081
    • Bass, N.M.1
  • 28
    • 84913553798 scopus 로고    scopus 로고
    • Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: A randomized, controlled trial
    • Dhiman, R. K. et al. Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. Gastroenterology 147, 1327-1337 e1323, doi: 10.1053/j.gastro.2014.08.031 (2014).
    • (2014) Gastroenterology , vol.147 , pp. 1327-1337
    • Dhiman, R.K.1
  • 29
    • 84912544732 scopus 로고    scopus 로고
    • Gut microbiota and metabolic syndrome
    • Festi, D. et al. Gut microbiota and metabolic syndrome. World J Gastroenterol 20, 16079-16094, doi: 10.3748/wjg.v20.i43.16079 (2014).
    • (2014) World J Gastroenterol , vol.20 , pp. 16079-16094
    • Festi, D.1
  • 30
    • 33845901507 scopus 로고    scopus 로고
    • Microbial ecology: Human gut microbes associated with obesity
    • Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023, doi: 10.1038/4441022a (2006).
    • (2006) Nature , vol.444 , pp. 1022-1023
    • Ley, R.E.1    Turnbaugh, P.J.2    Klein, S.3    Gordon, J.I.4
  • 31
    • 78649908827 scopus 로고    scopus 로고
    • The role of the gut microbiota in nonalcoholic fatty liver disease
    • Abu-Shanab, A. & Quigley, E. M. The role of the gut microbiota in nonalcoholic fatty liver disease. Nature reviews. Gastroenterology & hepatology 7, 691-701, doi: 10.1038/nrgastro.2010.172 (2010).
    • (2010) Nature Reviews. Gastroenterology & Hepatology , vol.7 , pp. 691-701
    • Abu-Shanab, A.1    Quigley, E.M.2
  • 32
    • 0034106289 scopus 로고    scopus 로고
    • A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
    • Malinchoc, M. et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31, 864-871, doi: 10.1053/he.2000.5852 (2000).
    • (2000) Hepatology , vol.31 , pp. 864-871
    • Malinchoc, M.1
  • 33
    • 84925198306 scopus 로고    scopus 로고
    • Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis
    • e751-752
    • O'Leary, J. G. et al. Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis. Clin Gastroenterol Hepatol 13, 753-759 e751-752, doi: 10.1016/j.cgh.2014.07.060 (2015).
    • (2015) Clin Gastroenterol Hepatol , vol.13 , pp. 753-759
    • O'Leary, J.G.1
  • 34
    • 84878562423 scopus 로고    scopus 로고
    • Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis
    • Bajaj, J. S., Ratliff, S. M., Heuman, D. M. & Lapane, K. L. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis. Aliment Pharmacol Ther 36, 866-874, doi: 10.1111/apt.12045 (2012).
    • (2012) Aliment Pharmacol Ther , vol.36 , pp. 866-874
    • Bajaj, J.S.1    Ratliff, S.M.2    Heuman, D.M.3    Lapane, K.L.4
  • 35
    • 84942309351 scopus 로고    scopus 로고
    • Are proton pump inhibitors affecting intestinal microbiota health?
    • Melgar, S. & Nieuwdorp, M. Are Proton Pump Inhibitors Affecting Intestinal Microbiota Health? Gastroenterology, doi: 10.1053/j. gastro.2015.08.039 (2015).
    • (2015) Gastroenterology
    • Melgar, S.1    Nieuwdorp, M.2
  • 36
    • 77950626219 scopus 로고    scopus 로고
    • Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis
    • Appenrodt, B. et al. Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis. Hepatology 51, 1327-1333, doi: 10.1002/hep.23440 (2010).
    • (2010) Hepatology , vol.51 , pp. 1327-1333
    • Appenrodt, B.1
  • 37
    • 79959383523 scopus 로고    scopus 로고
    • Metagenomic biomarker discovery and explanation
    • Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol 12, R60, doi: 10.1186/gb-2011-12-6-r60 (2011).
    • (2011) Genome Biol , vol.12 , pp. R60
    • Segata, N.1
  • 38
    • 84866396844 scopus 로고    scopus 로고
    • Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
    • Bajaj, J. S. et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol 303, G675-685, doi: 10.1152/ajpgi.00152.2012 (2012).
    • (2012) Am J Physiol Gastrointest Liver Physiol , vol.303 , pp. G675-685
    • Bajaj, J.S.1
  • 39
    • 77952771845 scopus 로고    scopus 로고
    • Quantitative assessment of the human gut microbiome using multitag pyrosequencing
    • Gillevet, P., Sikaroodi, M., Keshavarzian, A. & Mutlu, E. A. Quantitative assessment of the human gut microbiome using multitag pyrosequencing. Chem Biodivers 7, 1065-1075 (2010).
    • (2010) Chem Biodivers , vol.7 , pp. 1065-1075
    • Gillevet, P.1    Sikaroodi, M.2    Keshavarzian, A.3    Mutlu, E.A.4
  • 40
    • 67650021209 scopus 로고    scopus 로고
    • Microbial community profiling for human microbiome projects: Tools, techniques, and challenges
    • Hamady, M. & Knight, R. Microbial community profiling for human microbiome projects: Tools, techniques, and challenges. Genome Res 19, 1141-1152 (2009).
    • (2009) Genome Res , vol.19 , pp. 1141-1152
    • Hamady, M.1    Knight, R.2
  • 41
    • 66249145772 scopus 로고    scopus 로고
    • Statistical methods for detecting differentially abundant features in clinical metagenomic samples
    • White, J. R., Nagarajan, N. & Pop, M. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol 5, e1000352 (2009).
    • (2009) PLoS Comput Biol , vol.5
    • White, J.R.1    Nagarajan, N.2    Pop, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.